Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
ScientificWorldJournal. 2021 Dec 15;2021:8523091. doi: 10.1155/2021/8523091. eCollection 2021.
Extemporaneous compounding is a pharmacy practice to produce suitable pharmaceutical preparations when there are no commercially available, licensed, and age-specific dosage forms. Compared to the use of authorized drugs, these preparations have significant risks. Stability issues are one of the major concerns during the preparation of extemporaneous formulations.
The aim of this work was to study the stability of pediatric extemporaneous formulations of commercially available conventional solid dosage forms by reviewing systematically the currently available stability studies.
Articles were searched in the databases of the Web of Science, PubMed, Scopus, EMBASE, Cochrane Library, and Google Scholar. From all the searched articles, a total of 28 experimental studies reporting the stability of oral pediatric extemporaneous formulations were included based on the inclusion criteria. Oral extemporaneous formulations from commercially available dosage forms and pure drugs were considered. According to the United States and British Pharmacopeia (USP and BP), most extemporaneous formulations are accepted as chemically stable if they maintain ≥90% of the original drug amount, physically stable if there is no apparent change in physical property, and microbiologically stable if there is no growth of microorganisms in prepared formulations. . In this study, most extemporaneous pediatric oral formulations were chemically, physically, and microbiologically stable and retained more than 90% of the initial content. Very few studies did not include either a physical stability test or a microbiological stability test.
According to this systematic review, the chemical and physical instabilities as well as microbial growth on pediatric oral extemporaneous formulations are very rare in published experimental studies. Most studies show that extemporaneous preparations are stable at the ICH recommended storage conditions and duration. Generally, extemporaneously prepared oral formulations will be the promising option for child medications.
临时制剂是一种药房实践,当没有商业可获得的、许可的和特定年龄的剂型时,用于生产合适的药物制剂。与使用授权药物相比,这些制剂有很大的风险。在制备临时制剂时,稳定性问题是主要关注点之一。
本工作旨在通过系统地综述现有的稳定性研究,研究市售常规固体制剂的儿科临时制剂的稳定性。
在 Web of Science、PubMed、Scopus、EMBASE、Cochrane 图书馆和 Google Scholar 数据库中搜索文章。根据纳入标准,从所有搜索到的文章中,共纳入了 28 篇报告口服儿科临时制剂稳定性的实验研究。纳入了市售剂型和纯药物的口服临时制剂。根据美国和英国药典(USP 和 BP),如果临时制剂保持原始药物量的≥90%,则被认为在化学上是稳定的;如果物理性质没有明显变化,则在物理上是稳定的;如果制备的制剂中没有微生物生长,则在微生物学上是稳定的。在这项研究中,大多数儿科口服临时制剂在化学、物理和微生物学上都是稳定的,保留了超过 90%的初始含量。极少数研究既没有包括物理稳定性测试,也没有包括微生物稳定性测试。
根据这项系统综述,在已发表的实验研究中,儿科口服临时制剂的化学和物理不稳定性以及微生物生长非常罕见。大多数研究表明,临时制剂在 ICH 推荐的储存条件和时间内是稳定的。一般来说,临时制备的口服制剂将是儿童用药的有前途的选择。